These lab-produced options weren't designed with leisure use in mind. Inside the 1990s, John W. Huffman as well as a workforce of fellow chemists at Clemson College designed several of the very first formulas for synthetic cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impacts of canna